Onconetix, Inc. (ONCO) Financials

ONCO Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 16.4 million 3.0 million
March 31, 2026 14.8 million 3.1 million
Dec. 31, 2025 24.9 million 9.2 million
Sept. 30, 2025 19.7 million 16.3 million

ONCO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.9 million 7359
March 31, 2026 -2.1 million 22305
Dec. 31, 2025 -3.1 million 4234
Sept. 30, 2025 -3.2 million 9795

ONCO Net Income

No data available :(

ONCO Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.9 million - -
March 31, 2026 3.7 million - 42726
Dec. 31, 2025 5.2 million - 48774
Sept. 30, 2025 836556 - 6155

ONCO Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.2 million
March 31, 2026 628528
Dec. 31, 2025 3.3 million
Sept. 30, 2025 4.9 million

ONCO Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3440 - -
March 31, 2026 - 50818 2.0 million -
Dec. 31, 2025 3 24293 1.5 million -
Sept. 30, 2025 1 -3211 2.3 million -

ONCO Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 17120 12817
March 31, 2026 21457 23112
Dec. 31, 2025 303596 55912
Sept. 30, 2025 303651 34757

ONCO

Price: $0.65

52 week price:
0.65
209.50

Earnings Per Share: 749.08 USD

P/E Ratio: 0.00

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.0 million

Links: